Pathfinder Cell Therapy Inc
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies… Read more
Pathfinder Cell Therapy Inc (PFND) - Total Assets
Latest total assets as of September 2015: $39.00K USD
Based on the latest financial reports, Pathfinder Cell Therapy Inc (PFND) holds total assets worth $39.00K USD as of September 2015.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Pathfinder Cell Therapy Inc - Total Assets Trend (1999–2014)
This chart illustrates how Pathfinder Cell Therapy Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Pathfinder Cell Therapy Inc - Asset Composition Analysis
Current Asset Composition (December 2014)
Pathfinder Cell Therapy Inc's total assets of $39.00K consist of 68.9% current assets and 31.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 24.5% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $33.00K | 31.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1999–2014)
This chart illustrates how Pathfinder Cell Therapy Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Pathfinder Cell Therapy Inc's current assets represent 68.9% of total assets in 2014, a decrease from 93.1% in 1999.
- Cash Position: Cash and equivalents constituted 24.5% of total assets in 2014, down from 90.7% in 1999.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, an increase from 0.0% in 1999.
- Asset Diversification: The largest asset category is intangible assets at 31.1% of total assets.
Pathfinder Cell Therapy Inc Competitors by Total Assets
Key competitors of Pathfinder Cell Therapy Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Pathfinder Cell Therapy Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Pathfinder Cell Therapy Inc generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Pathfinder Cell Therapy Inc is currently not profitable relative to its asset base.
Pathfinder Cell Therapy Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.00 | 0.01 | 0.13 |
| Quick Ratio | 0.00 | 0.01 | 0.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-6.76 Million | $ -5.68 Million | $ -977.00K |
Pathfinder Cell Therapy Inc - Advanced Valuation Insights
This section examines the relationship between Pathfinder Cell Therapy Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -31.6% |
| Total Assets | $106.00K |
| Market Capitalization | $0.99 USD |
Valuation Analysis
Below Book Valuation: The market values Pathfinder Cell Therapy Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Pathfinder Cell Therapy Inc's assets decreased by 31.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Pathfinder Cell Therapy Inc (1999–2014)
The table below shows the annual total assets of Pathfinder Cell Therapy Inc from 1999 to 2014.
| Year | Total Assets | Change |
|---|---|---|
| 2014-12-31 | $106.00K | -31.61% |
| 2013-12-31 | $155.00K | -56.46% |
| 2012-12-31 | $356.00K | -44.72% |
| 2011-12-31 | $644.00K | +344.14% |
| 2010-12-31 | $145.00K | -88.12% |
| 2009-12-31 | $1.22 Million | -63.34% |
| 2008-12-31 | $3.33 Million | -1.22% |
| 2007-12-31 | $3.37 Million | -19.29% |
| 2006-12-31 | $4.18 Million | +283.30% |
| 2005-12-31 | $1.09 Million | -51.77% |
| 2004-12-31 | $2.26 Million | +122.88% |
| 2003-12-31 | $1.01 Million | +97.28% |
| 2002-12-31 | $514.00K | +14.48% |
| 2001-12-31 | $449.00K | -53.52% |
| 2000-12-31 | $966.00K | +21.05% |
| 1999-12-31 | $798.00K | -- |